PTPRC and melanoma: Furthermore, to comprehensively characterize the changes within the TME during TREM1 deficiency and anti-PD-1 ICB, we performed scRNA-Seq analysis of the CD45+ TICs in melanoma-bearing Trem1+/+ mice receiving the various treatments.